CY1118741T1 - Αναπνευστικος συγκυτιακος ιος με μια γονιδιωματικη ατελεια συμπληρωμενη in trans - Google Patents
Αναπνευστικος συγκυτιακος ιος με μια γονιδιωματικη ατελεια συμπληρωμενη in transInfo
- Publication number
- CY1118741T1 CY1118741T1 CY20171100266T CY171100266T CY1118741T1 CY 1118741 T1 CY1118741 T1 CY 1118741T1 CY 20171100266 T CY20171100266 T CY 20171100266T CY 171100266 T CY171100266 T CY 171100266T CY 1118741 T1 CY1118741 T1 CY 1118741T1
- Authority
- CY
- Cyprus
- Prior art keywords
- virus
- pulmonary
- trans
- viral
- viruses
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 7
- 230000000241 respiratory effect Effects 0.000 title 1
- 230000002685 pulmonary effect Effects 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 230000003612 virological effect Effects 0.000 abstract 4
- 230000035772 mutation Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108091006027 G proteins Proteins 0.000 abstract 1
- 102000030782 GTP binding Human genes 0.000 abstract 1
- 108091000058 GTP-Binding Proteins 0.000 abstract 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 210000002845 virion Anatomy 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
- C07K14/135—Respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18532—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18551—Methods of production or purification of viral material
- C12N2760/18552—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18561—Methods of inactivation or attenuation
- C12N2760/18562—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL0300930 | 2003-12-24 | ||
| PCT/NL2004/000911 WO2005061698A1 (en) | 2003-12-24 | 2004-12-24 | A respiratory syncytial virus with a genomic deficiency complemented in trans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1118741T1 true CY1118741T1 (el) | 2017-07-12 |
Family
ID=34709376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100266T CY1118741T1 (el) | 2003-12-24 | 2017-02-28 | Αναπνευστικος συγκυτιακος ιος με μια γονιδιωματικη ατελεια συμπληρωμενη in trans |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US9107939B2 (https=) |
| EP (2) | EP2500419B1 (https=) |
| JP (1) | JP4814799B2 (https=) |
| KR (1) | KR101266715B1 (https=) |
| CN (1) | CN1922309B (https=) |
| AU (1) | AU2004303719B2 (https=) |
| BR (1) | BRPI0418093A (https=) |
| CA (1) | CA2551009C (https=) |
| CY (1) | CY1118741T1 (https=) |
| DK (1) | DK1699919T3 (https=) |
| EA (1) | EA011878B1 (https=) |
| ES (2) | ES2618523T3 (https=) |
| HU (1) | HUE032898T2 (https=) |
| IL (1) | IL176500A (https=) |
| LT (1) | LT1699919T (https=) |
| NO (1) | NO334756B1 (https=) |
| NZ (1) | NZ548107A (https=) |
| PL (1) | PL1699919T3 (https=) |
| PT (1) | PT1699919T (https=) |
| SI (1) | SI1699919T1 (https=) |
| TR (1) | TR201808496T4 (https=) |
| WO (1) | WO2005061698A1 (https=) |
| ZA (1) | ZA200605218B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201121210D0 (en) * | 2011-12-09 | 2012-01-18 | Health Prot Agency | Respiratory infection assay |
| WO2013133702A1 (en) | 2012-03-05 | 2013-09-12 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws | Methods and compositions for stabilizing dried biological materials |
| CN113322264B (zh) | 2013-03-14 | 2024-05-31 | 爱默蕾大学 | 具有沉默突变的重组rsv、其相关疫苗和方法 |
| BR112015031541A2 (pt) | 2013-06-17 | 2017-07-25 | De Staat Der Nederlanden Vert Door De Mini Van Vws Miniie Van Volksgezondheid Welzijn En Sport | métodos para o impedimento da agregação de componentes virais |
| CN106659777A (zh) | 2014-06-13 | 2017-05-10 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合产品 |
| MX2018005462A (es) | 2015-10-29 | 2018-08-01 | Univ Emory | Composiciones inmunogénicas de rsv quimérico y métodos de uso. |
| US10626126B2 (en) * | 2016-04-08 | 2020-04-21 | Pulmocide Limited | Compounds |
| CN112746059A (zh) * | 2020-09-15 | 2021-05-04 | 清华大学 | 基于病毒结构蛋白遗传互补的冠状病毒细胞模型 |
| CN112501134B (zh) * | 2020-12-09 | 2023-01-20 | 贵州医科大学附属医院 | 一种人呼吸道合胞病毒毒株及其应用 |
| CN114990079B (zh) * | 2022-04-29 | 2023-07-04 | 广州医科大学附属第一医院（广州呼吸中心） | 治疗性缺陷干扰颗粒及其在制备用于防治rsv病毒感染的产品中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT702085E (pt) | 1994-07-18 | 2004-04-30 | Karl Klaus Conzelmann | Virus de arn de cadeia negativa nao segmentada infeccioso recombinante |
| US5789229A (en) | 1994-09-30 | 1998-08-04 | Uab Research Foundation | Stranded RNA virus particles |
| AU727923B2 (en) | 1995-09-27 | 2001-01-04 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| EP1035205A1 (en) | 1999-03-08 | 2000-09-13 | Stichting Dienst Landbouwkundig Onderzoek | Non-spreading pestivirus |
| AU2001263896A1 (en) | 2000-06-23 | 2002-01-14 | Akzo Nobel N.V. | Attenuated bovine respiratory syncytial virus |
| WO2003029416A2 (en) * | 2001-10-01 | 2003-04-10 | Uab Research Foundation | Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof |
-
2004
- 2004-12-24 CN CN2004800420638A patent/CN1922309B/zh not_active Expired - Fee Related
- 2004-12-24 HU HUE04808827A patent/HUE032898T2/hu unknown
- 2004-12-24 NZ NZ548107A patent/NZ548107A/en not_active IP Right Cessation
- 2004-12-24 TR TR2018/08496T patent/TR201808496T4/tr unknown
- 2004-12-24 ES ES04808827.2T patent/ES2618523T3/es not_active Expired - Lifetime
- 2004-12-24 EP EP12172153.4A patent/EP2500419B1/en not_active Expired - Lifetime
- 2004-12-24 BR BRPI0418093-3A patent/BRPI0418093A/pt not_active Application Discontinuation
- 2004-12-24 JP JP2006546873A patent/JP4814799B2/ja not_active Expired - Fee Related
- 2004-12-24 LT LTEP04808827.2T patent/LT1699919T/lt unknown
- 2004-12-24 WO PCT/NL2004/000911 patent/WO2005061698A1/en not_active Ceased
- 2004-12-24 CA CA2551009A patent/CA2551009C/en not_active Expired - Fee Related
- 2004-12-24 PL PL04808827T patent/PL1699919T3/pl unknown
- 2004-12-24 US US10/583,800 patent/US9107939B2/en not_active Expired - Fee Related
- 2004-12-24 DK DK04808827.2T patent/DK1699919T3/en active
- 2004-12-24 PT PT48088272T patent/PT1699919T/pt unknown
- 2004-12-24 EP EP04808827.2A patent/EP1699919B1/en not_active Expired - Lifetime
- 2004-12-24 EA EA200601218A patent/EA011878B1/ru not_active IP Right Cessation
- 2004-12-24 SI SI200432377A patent/SI1699919T1/sl unknown
- 2004-12-24 AU AU2004303719A patent/AU2004303719B2/en not_active Ceased
- 2004-12-24 KR KR1020067014600A patent/KR101266715B1/ko not_active Expired - Fee Related
- 2004-12-24 ES ES12172153.4T patent/ES2670713T3/es not_active Expired - Lifetime
-
2006
- 2006-06-22 IL IL176500A patent/IL176500A/en active IP Right Grant
- 2006-06-23 ZA ZA200605218A patent/ZA200605218B/en unknown
- 2006-06-26 NO NO20062967A patent/NO334756B1/no not_active IP Right Cessation
-
2015
- 2015-07-31 US US14/815,131 patent/US9889168B2/en not_active Expired - Fee Related
-
2017
- 2017-02-28 CY CY20171100266T patent/CY1118741T1/el unknown
-
2018
- 2018-01-09 US US15/865,630 patent/US10967014B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1118741T1 (el) | Αναπνευστικος συγκυτιακος ιος με μια γονιδιωματικη ατελεια συμπληρωμενη in trans | |
| Vignuzzi et al. | Defective viral genomes are key drivers of the virus–host interaction | |
| Rezelj et al. | The defective component of viral populations | |
| CY1106848T1 (el) | Τροποποιημενος ιος vaccinia ankara για τον εμβολιασμο νεογνων | |
| CY1123152T1 (el) | Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους | |
| CY1111908T1 (el) | Εμβολιο γριπης | |
| DE122011100039I1 (de) | DNA-transfektionssystem zur erzeugung von infektiosen negativstrangigen RNA virus. | |
| EA200501890A1 (ru) | Вирусы гриппа высокого титра для приготовления вакцин и генной терапии | |
| MX2010003202A (es) | Metodo para producir virus de la gripe. | |
| CY1106207T1 (el) | Αντιιικα παραγωγα νουκλεοζιτων | |
| BRPI0416187A (pt) | método de prevenir fusão de vìrus: célula inibindo a função da região de iniciação de fusão em vìrus de rna tendo proteìnas de envelope fusogênico de membrana da classe i | |
| CY1110272T1 (el) | Αθανατοποιημενες κυτταρικες σειρες πτηνων για παραγωγη ιου | |
| ATE396739T1 (de) | Entwicklung einer vakzine zur prävention von infektionen mit filovirus bei primaten | |
| ATE469972T1 (de) | Multiplasmid-system zur erzeugung des grippevirus | |
| DE60327190D1 (de) | Zellen zum nachweis von influenza- und parainfluenzaviren | |
| EP4179074A4 (en) | PROCESS FOR PRODUCING MODIFIED VIRUS GENOMES AND PRODUCTION OF MODIFIED VIRUSES | |
| ATE399210T1 (de) | Knockout-mutante von vaccinia-virus und verwendung davon | |
| WO2006136448A3 (en) | Attenuated sars and use as a vaccine | |
| CY1106570T1 (el) | Σταθερες, εξασθενημενες μεταλλαγμενες μορφες ιου λυσσας και ζωντανια εμβολια αυτων | |
| Simon et al. | Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA | |
| EA200701695A1 (ru) | Рнк вирусы с ослабленной способностью к репликации в качестве вакцин | |
| AR047581A1 (es) | Vacunas de calicivirus felino | |
| ATE547116T1 (de) | Kombinationsimpfstoff | |
| ATE504653T1 (de) | Vaccinia virus wirtspektrum gene zur erhöhung des titers von avipoxviren | |
| CY1105704T1 (el) | Πρωτεϊνες του πνευμονοϊου ns ανταγωνιζονται την ανταποκριση της ιντερφερονης(ifn) |